Product Description
The total market for Europe’s cardiac rhythm management devices market is growing at a rate of 3.9%, which will take the 2018 market value of €2.2 billion up to €2.9 billion by 2025.
Reprocessed diagnostic electrophysiology (EP) catheters accounted for a significant percentage of all diagnostic EP catheters used. Reprocessed catheters have a much lower ASP than non-reprocessed catheters, and so this limits the market. To counter this effect, companies are placing more marketing emphasis on high-end catheters that are not reprocessed. The practice of reprocessing EP devices is especially visible within EP labs.
The full report suite on the European market for cardiac rhythm management, electrophysiology and cardiac ablation includes pacemakers, implantable cardioverter-defibrillators (ICDs), cardiac resynchronization therapy devices (CRTs), cardiac leads, electrophysiology (EP) lab systems, diagnostic EP catheters and cardiac ablation catheters.
Europe Cardiac Rhythm Management Segmentation
While this report suite contains all Europe cardiac rhythm management device data, each of the markets are also available as stand alone MedCore reports. This allows you to get access to only the cardiac rhythm management market research that you need. You can view all these included reports and segmentation here:
- Europe Market Report for Pacemakers – MedCore – In-depth analysis of the Pacemaker Market. Chapter includes details on single and dual-chamber device markets.
- Europe Market Report for Implantable Cardioverter Defibrillators – MedCore – In-depth analysis of the ICD Market. Chapter includes details on single and dual-chamber ICDs and more.
- Europe Market Report for Cardiac Resynchronization Therapy Devices – MedCore – In-depth analysis of the of the CRT Market. Chapter includes details on Initial Placement CRT devices and Replacement CRT devices.
- Europe Market Report for Cardiac Ablation Catheters – MedCore – In-depth analysis of the Cardiac Ablation Catheter Market. Chapter includes details on RF Ablation Catheters and Cryoablation Catheters.
- OTHER INFORMATION – Company Profiles and SWOT, Disease Overviews, & Related Press Releases from Top Competitor
Buying all of these reports together in this suite package will provide you with substantial discounts from the separate prices. Request Pricing to Learn More
Europe Cardiac Rhythm Management Market Report Data Types Included
- Unit Sales, Average Selling Prices, Market Value & Growth Trends
- Forecasts Until 2025, and Historical Data to 2015
- Market Drivers & Limiters for Each Cardiac Rhythm Management Device Segment
- Competitive Analysis with Market Shares for Each Segment
- Recent Mergers & Acquisitions
- Cardiac Rhythm Management Procedure Volumes
- Disease Overviews and Demographic Information
- Company Profiles, Product Portfolios and SWOT for Top Competitors
- Related Press Releases from Top Competitors
Europe Cardiac Rhythm Management Companies Analyzed
Medtronic led the total market for cardiac rhythm management (CRM), electrophysiology (EP) and ablation devices, due to its dominance in the pacemaker, ICD and CRT segments. Medtronic has been able to retain its position in the CRM market through brand recognition, strong customer
support and a large sales force.
Other major competitors in the market include Abbott and Boston Scientific. These companies also offer a wide range of electrophysiology (EP) and cardiac ablation products and sell them through large distribution networks.
